The screening for diabetic nephropathy in diabetes clinic in Khartoum- Sudan by Ahmed, SAE & Gadou, MOEH
 





The screening for diabetic nephropathy in diabetes clinic in Khartoum- Sudan 
Sid Ahmed Elkhidir Ahmed1 and Mohammed Osman El Hassan Gadour2 
 
ABSTRACT 
Background: diabetes mellitus and its complications is one of the major 
health problems. This study is about the screening for one of these 
complications -diabetic nephropathy- in our clinical practice in Khartoum 
Sudan.   
Objectives: The main objective is to determine whether the clinical practice 
in the diabetes clinics in Khartoum- Sudan is following the recommended 
guidelines for the screening for diabetic nephropathy. 
Study Design: Prospective cross- sectional study.  
Populations: during the period from Jan-March 2008, 98 diabetic patients 
with type 1 or type 2 were randomly selected from patients attending the 
outpatient diabetes clinic in Omdurman Teaching Hospital. 
Methodology: ninety eight adult type1 and 2 diabetic patients were studied using simple, direct, 
standardized questionnaire, previous records were seen and a urine sample for each patient was 
examined for proteinuria.  
Results: 6.1% of the total number of patients had urine examination on regular bases, 75.5% rarely 
had urine examination, while 18.4% had their urine never been examined before in the diabetes 
clinics. None of patients was diagnosed as having diabetic nephropathy or seen by a nephrologist. 
Only 7.1% of the total patients were using ACE inhibitors or ARB agents and these were prescribed 
for indications other than diabetic nephropathy. Testing urine of our patients we found that 18.4% 
had macroalbuminuria, 40.8% microalbuminuria, while40.8% had negative results. The majority of 
the patients with either type of albuminuria were in the age group 51-65 years and most of them had 
type 2 diabetes.     
Conclusion: A large number of our patients had evidence of diabetic nephropathy. However, none 
of them had been screened before for that. Despite the small number of patients, this study raises a 
serious alarm regarding the clinical practice in our diabetes clinics in Khartoum Sudan and it 
strongly recommends urgent intervention by the authorities to implement the international 
guidelines of screening and management of these patients. 
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t least 171 million people worldwide 
have diabetes; this figure is likely to 
be more than double by 2030.  
Diabetes has become one of the major causes 
of premature illness and death in most 
countries1.  
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 Diabetic nephropathy is the single most 
important cause of end stage renal disease 
(ESRD) in the western countries. In the U.K it 
accounts for20% of patients requiring renal 
replacement therapy2.   
Around 10% to 42% of patients with type 1 
and type 2diabetes develop microalbuminuria, 
which is largely related to disease duration3, 4 
Microalbuminuria predicts early mortality in 
patients with diabetes5,6 and is an important  
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cardiovascular risk factor7 .  
The median life expectancy is decreased by 
four to 14 years, and the effect was greatest in 
patients who developed diabetes during 
childhood. It was found that the incidence of 
ESRD was reduced if screening program is 
applied8.        
Patients with type 1 diabetes who have 
microalbuminuria were found to have a 
relative risk of cardiovascular death that is 1.2 
times that of normoalbuminuric type 1 
diabetic patients 9.   
 Screening programs are generally focused on 
conditions with great effect on health and 
which benefit from early interventions. 
Chronic kidney disease (CKD) especially that 
attributed to diabetes certainly fits this 
criterion.      
Early detection of diabetic nephropathy 
allows early treatment and hence decreases 
the number of patient reaching ESRD. This 
has important psychosocial and financial 
consequences on the community10 
 Objectives of the study 
The main objective is to determine whether 
the clinical practice in the diabetes clinics in 
Khartoum Sudan is following the 
recommended guide lines for screening for 
diabetic nephropathy, and to determine the 
prevalence of macro- and microalbuminuria 
caused by diabetic nephropathy among the 
diabetic patients attending the diabetes 
clinics. 
 
 Research methods 
 
Study design: this is a cross-sectional 
prospective study  
Populations: during the period from Jan-Mar 
2008, 98 diabetic patients with type 1 or 
type2 were randomly selected from patients 
attending the outpatient diabetic clinic in 
Omdurman Teaching Hospital according to 
the following criteria: 
All patients were diabetic according to the 
W.H.O criteria (for more than 5years in type 
1 patients) and were seen regularly in the out 
patient clinic. The target age group is 20 to 70 
years. 
 
Exclusion criteria:[ to avoid misleading 
results of urine analysis]: 
Patients with known renal impairment, 
ESRD, pregnancy, concomitant systemic 
illness, febrile illness, UTI, or severe 
hypertension.  Formal consents were taken 
and questionnaires were filled.  
A morning urinary sample was taken from 
each patient in sterile container. Thymol 
crystals were used as a preserver. Urine was 
examined for albuminuria using dipstick 
method and also by sulphsalicylic acid 
solution. Patients with positive results (1+ or 
more) were considered to have 
macroalbuminuria that need confirmation. At 
the same time urine deposit was examined to 
exclude other causes such as urinary tract 
infection. 
Patients with negative results were further 
screened for micro albuminuria by measuring 
urinary albumin/creatinine ratio, a ratio of 
>2.5 in males or> 3.5 in females is considered 
as microalbuminuria. The data were analyzed 
using the SPSS, the results were discussed.   
The results 
Out of 98 diabetic patients 36.7% were males.  
They had the disease for 0.2-40 years. (fig1) 
Type 1 DM constituted 24.5% of the 




Figure (1): duration of diabetes (in years)  
  
The age ranged between 20 and 70 years ( fig 
2). Hypertension was detected in 18.4% of the 
patients, while 6.1% were known to have 
ischaemic heart diseases (I.H.D), 1% had a 
history of myocardial infarction, 3.1% had 
cerebrovascular accident, and 2% had history 
of limb ischaemia. 
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Figure(2): age distribution in years 
 
Only 7.1% of the total patients were using 
ACE inhibitors or ARB agent and they were 
used for reasons other than diabetic 
nephropathy.  
Only 6.1% of the patients had urine 
examination on regular bases, 75.5% rarely 
had urine examination, while the urine was 
never examined before in the diabetes clinic 
in 18.4%of the patients. Interestingly, when 
the urine was examined it was mainly for 
sugar and acetone (62.2%), or general 
analysis (19.4 %).( table1). 
 
Table (1) The type of urine examination 
performed for our patients attending the 
diabetes clinic 
 
Type of test requested No. Percent 
Sugar and acetone 61 62.2 
General examination 19 19.4 
Alb/creatinine 0 0 
24hrs urinary protein 0 0 
Never done 18 18.4 
total 98 100 
 
None of the patients was diagnosed as having 
diabetic nephropathy or was seen by a 
nephrologist. 
The results of the screening were as 
follows:- 
Macroalbuminuria was detected in 18.4% of 
the patients while 40.8% were positive for 
microalbuminuria, and 40.8% had negative 
results. Half of the patients with 
macroalbuminuria were in the age group51-
65 years ( fig3). 
 
 
Figure (3) shows the distribution of 
albuminuria according to the age group in 
years. 
 
22.2% of the patients were males, and 33.3% 
had type 1 diabetes, 27.8% were having 
diabetes for 16-20 years (table 2) ,  22.2% 
were hypertensive while 5.6% were known to 
have IHD.    44.4% of the patients gave 
history of hospitalization/year for diabetes 
control and/or management of metabolic 
complication of diabetes.    
 
Table (2) shows distribution of albuminuria 
according to the duration of diabetes in     
years 
 
Duration Macro Micro 
0-5 years 4 (22.2%) 15 (3705%) 
6-10 years 3 (16.7%) 9 (22.5%) 
11-15 years 4 (22.2%) 5 (12.5%) 
16-20 years 5 (27.8%) 4 (10%) 
>20 years 2 (11.1%) 7 (17.5%) 
 
 
Among patients with microalbuminuria: 
The majority (80%) of patients with 
microalbuminuria had type 2 diabetes,  with 
female predominance (57.5%) .  60% were in 
the age group 51-65 years (fig3).  The 
majority of the patients (37.5%) were having 
diabetes for 5 years only (table 2),  22.5% 
were hypertensive while one patient (2.5%) 
had IHD,  another one had M.I,  two 
patients(5%) had history of CVA, while two 
patients (5%) gave a history of limb 
amputation. The urine examination when 
done it was for the presence of sugar and 
acetone in 71.9%.  
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     In this study a total number of 98 patients 
were screened, 36.7% of them were males. 
This aproximately represents the male: female 
attendance ratio in the referred clinic which 
was found to be 1 :2 . This may reflect the 
distribution of diabetes among Sudanese 
patients or it may indicate more care about 
follow up in female diabetic patients. Our 
finding is in consistence with literature11,12  
The figures representing co morbid conditions 
including hypertension,  ischaemic heart 
diseases myocardial infarction, 
cerebrovascular accident, and  limb ischaemia 
may not represent the real situation in the 
community as many diabetic patients with 
vascular complications loose their attendance 
to diabetic clinics and are followed up in 
other related specialized clinics 
(cardiovascular, neurology, nephrology) etc.  
Also patient with renal impairment and/or 
severe hypertension were excluded from the 
study as mentioned earlier. Those patients are 
likely to have more incidences of vascular 
complications of diabetes such as myocardial 
infarction or ischaemic limb(s).         
   Urine examination during follow-up was 
performed regularly on only 6.1% of the total 
number of patients, 75.5% of the patients 
rarely had urine examination, while in 18.4% 
the urine was never examined in the diabetes 
clinic. This reflects the common wrong 
believe that as urine examination is not a 
good reflection of the blood glucose level, it 
is no longer needed except for exclusion of 
ketoneuria or when urinary tract infection is 
suspected. This indicates that the importance 
of examining the urine to look for possible 
complications of diabetes in relation to the 
renal system is underestimated in our clinical 
practice. Urine examination is not a routine 
practice in our clinics. This is probably 
because of absence of clear guidelines 
mastering that.  As a result many 
abnormalities are missed as far as they remain 
silent. Even when the urine was examined it 
was either for sugar and acetone in 62.2%, or 
the request was for general examination in 
19.4% when there is abnormally high blood  
 
 
glucose. Miller and Hirsh13  reviewed 157 
diabetic patients and found that 50% had not 
had urinalysis during the two years of the 
study, only 13% had subsequently received a 
24 hrs urinary examination. On the other hand 
another study14 reported some-what better 
results. None of our patients had urinary 
screening for proteinuria neither for 
macroalbuminuria nor for microalbuminuria.  
If we assume that general examination of the 
urine includes testing for macroalbuminuria 
as part of the general examination, then only 
19.4% of the total number of patients had the 
test. This is an unacceptable low figure. 
Considering that the test in most of the time 
was conducted in those patients who have 
factors that cause false positive results for the 
presence of macroalbuminuria such as urinary 
tract infection or fever, then this will 
complicate things more and draw a 
conclusion that performing general 
examination for the urine in this setting is of 
limited value in detecting macroalbuminuria 
due to diabetic nephropathy. Similar results 
were reported elsewhere15. 
 Screening test for microalbuminuria was 
completely ignored in our general practice 
and in the specialized centers. A number of 
cases of diabetic renal diseases are missed 
when there will be a benefit of treatment and 
are only discovered late. Our results contrasts 
a report from India  that described the practice 
of primary care physicians related to diabetic 
nephropathy screening and management 16 
which noted that 86% of the physicians 
reported screening more than 50% of their 
patients of type 1 diabetes for overt 
albuminuria, as did 82% of physicians for 
their patients with type 2 diabetes. As 
expected none of our patients was seen by a 
nephrologist or diagnosed as having diabetic 
nephropathy. This malpractice is present in 
many parts of the world including some 
developed countries12-17. 
The lack of the appropriate facilities is one of 
the factors that may not allow clinician to 
follow a guideline in their clinical practice in 
the developing countries, but the condition is 
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not so regarding screening for early diabetic 
nephropathy as urine examination has the 
advantage of being simple, quick, cheap and 
reliable for detecting early nephropathy in 
diabetes .On the other  hand the care of the 
patients with renal diseases secondary to 
diabetes is much  more costly than a program  
that detects and treats diabetic nephropathy in 
its earlier stages.         
In our study we found that 18.4% of the 
patients had a positive urine test for 
macroalbuminuria,  40.8% were positive for 
microalbuminuria. In a study done in K.S.A18 
nephrotic range proteinuria was detected in 
5.6%, clinical proteinuria in30.4% and 
microalbuminuria in 16.8% of diabetic 
patients. In our patients nephrotic range 
proteinuria was not reported. This can be 
explained by the fact that this group of 
patients is either excluded from the study 
because of renal impairment or they are not 
attending the diabetes clinic as they are 
followed up by the nephrology clinics. The 
percentage of patients with either type of 
proteinuria is higher in our patients, this may 
reflect true increased prevalence of diabetic 
nephropathy in our patients as a result of the 
absence of screening for early diabetic 
nephropathy and consequently patients do not 
receive early treatment that regress or stop the 
progression of the disease.  Although these 
patients need further confirmatory tests as 
recommended by the guidelines, but one need 
to consider that a lot of our patients have poor 
or no attendance for regular follow up so they 
are likely to be missed by a screening 
program dealing with patients in the referred 
clinics. We believe that determinacy of the 
prevalence of diabetic nephropathy needs a 
more large scale study.  
    Strikingly 93.7% of the patients with 
positive tests for macroalbuminuria had their 
urine been tested for sugar and acetone in the 
past.  
 These results of this study reflect two facts 
firstly as the diagnoses of diabetic 
nephropathy is missed due to the lack of 
screening, our patients with early diabetic 
nephropathy did not receive proper treatment 
as recommended. Secondly even when there 
was concomitant hypertension, in the majority 
of patients the choice of the anti hypertension 
drug was not the right one according to the 
guidelines.  
In our study we found that the majority of the 
patients with positive results were in the age 
group 51-65 years (50% of patients with 
macroalbuminuria and 60% of patients with 
microalbuminuria), this can be explain by the 
fact that these nephropathic changes  are more 
likely to develop in patients who have 
diabetes for longer period and, this is evident 
in patients with macroalbuminuria as the 
largest percent was among patients who have 
diabetes for 16-20 years(fig3) a durations at 
which complications are expected to develop. 
However, this is not true for patients with 
microalbuminuria as the majority were 
diabetic for 5years (table1). This can be 
explained by the fact that the majority of 
patients with microalbuminuria (80%) were 
type 2diabetic patients who may have the 
disease for longer period before they are 
diagnosed and who are likely to present with 
complications of diabetes at the time of 
diagnoses. In fact this is the idea behind 
screening of type 2 diabetic patients for 
diabetic nephropathy at the time of the 
diagnoses. Another point is that this age 
group is likely to have other risk factors for 
diabetic nephropathy such as hypertension 
more than younger age groups. 
 The study found that in patient with 
macroalbuminuria there was a history of 
hospitalization for diabetes control and/or 
metabolic complication of diabetes per year in 
44.4% of the patients with macroalbuminuria 
and in 44% of patients with microalbuminuria 
indicating poor glycemic control and hence 
predisposition to diabetic nephropathy. 
Only 5.6% of our patients were using ACEI 
and these agents were prescribed for reasons 
other than diabetic nephropathy in all 
patients.  Our results are not in concordance 
with the studied done by others16 who found 
that ACEI was prescribed frequently (62%-
76% -82% of patients) to treat albuminuria 
when hypertension is present but less often 
when hypertension is absent (in 48% to 58% 
of patients). Some studies 19 had found that 
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the use of ACEI in all diabetic patients is 
cost-effective and might be applied instead of 
performing screening test; this point should 
be considered in our situation because if we 
treat all patients with these agents we can 
overcome the problems of the lack of 
screening as well as the patients’ regular 
follow-up attendance   
Limitations: the small number of the studied 
patients, the inappropriate recording of old 
information in the patients’ files and the need 
for confirmation of albuminuria according to 
the guidelines are the main limiting factors in 
this study.     
 
Conclusion 
A large number of our diabetic patients have 
abnormal urinary protein excretion and they 
need further tests to confirm the presence of 
proteinuria and proper management to 
prevent or slow their progression towards 
ESRD. The clinical practice in the diabetes 
clinic in Sudan is not following the 
international guidelines regarding the 
screening for diabetic nephropathy; hence a 
significant number of patients with diabetic 
nephropathy are missed. Consequently these 
patients loose the benefit from early 
intervention which is found to be the most 
important point in the management of these 
patients. 
 The use of ACEI and ARB is very limited in 
our diabetes clinic even in the presence of 
hypertension a point that needs further 
attention in our practice. 
 Diabetic nephropathy is found to be more 
common in patients above 50 years old, in 
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